Form 4 for NRIX Nurix Therapeutics, Inc.
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-10 · accession 0001209191-22-002849 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-11 | 2022-01-10 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2022-01-11 | 2022-01-10 | NRIX | Ring Christine | GC | S - Sale+OE | $27.14 | -1,200 | 1,286 | -48% | -$32.6K |
| D | 2022-01-11 | 2022-01-10 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | -1,200 | 100.1K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | M | A | 1,200 | $1.86 | 2,486 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-10 | S | D | 1,200 | $27.14 | 1,286 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-01-10 | M | D | 1,200 | $0.00 | 100,066 | D | $1.86 · — to 2029-09-30 | 1,200 Common Stock | (F2) The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. |